Connect with us

Legal & Regulation

FDA Requests $5 Million Budget for CBD Initiative on Testing and Legal Issues

Jane Summers

Published

on

CBD Companies Warned by the FDA to Stop Making Claims Related to Opioids
- Ad -

On Tuesday, President Trump sent a budget request to Congress. The request included a $5 million budget request for the FDA in order to act upon hemp CBD initiatives.

The request can be read in full here.

According to a news report by Compass Natural Marketing, Daniel Fabricant, Ph.D., President and CEO of the Natural Products Association (NPA) stated:

“This is a step in the right direction and is an indication that the agency has the resources to regulate the industry. However, this does not go far enough to specifically address the issue of setting safe level of daily consumption for [hemp] CBD products. Setting a safe level of consumption for [hemp] CBD products is the best way to move forward with this promising new product while protecting consumers.”

Daniel Fabricant, President and CEO of Natural Products Association, also shared in the aforementioned report that the new funding is welcome, but that it also puts the cart before the horse. The Natural Products Association advocates that the first thing that the FDA should do is to establish safe exposure levels for hemp CBD, and such levels would take into account the many sources of molecules that consumes have available to them, including supplements, beverages, and food.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or medical advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com